| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/02/2006 | US20060024271 Treatments for viral infections using IFN cytokines and ribavirin, alone or in combination |
| 02/02/2006 | US20060024270 Compositions and methods for preventing or treating encephalitis with interferon |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/02/2006 | US20060024266 Side-chain crystallizable polymers for medical applications |
| 02/02/2006 | US20060024265 Administering sodium-binding polymer of a core-shell, having an in vivo sodium binding capacity of 4 mmol or more per gram of polymer for removing sodium in gastro-intestinal tract ; treatment of hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, fluid overload |
| 02/02/2006 | US20060024264 Antimicrobial copolymers and uses thereof |
| 02/02/2006 | US20060024243 Foamable compositions containing nitro-imidazoles, processes for preparing same and methods of treatment utilizing same |
| 02/02/2006 | US20060024242 Solubilizing liquid of refractory element and producing method thereof |
| 02/02/2006 | US20060024241 Vitamin B12 compositions |
| 02/02/2006 | US20060024239 Persistent post-viral cough drug and treatment method |
| 02/02/2006 | US20060024238 Compositions and methods using proton pump inhibitors |
| 02/02/2006 | DE20221486U1 Tamsulosin-Tabletten mit modifizierter Freisetzung Tamsulosin tablets with modified release |
| 02/02/2006 | DE10258008B4 Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Heterocyclic Fluorglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
| 02/02/2006 | DE102004034744A1 Rendering T-lymphocyte-attacking viruses harmless in the human body, especially for treating AIDS and related disorders, using menadione or derivative to induce selective oxidative death of T-lymphocytes |
| 02/02/2006 | DE102004034690A1 Methyliden-D-xylopyranosyl-und Oxo-D-xylopyranosyl-substituierte Phenyle, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Methylidene-D xylopyranosyl and oxo-D-xylopyranosyl-substituted phenyls, medicaments containing these compounds, their use and process for their preparation |
| 02/02/2006 | DE102004034683A1 Verfahren zur Isolierung von α-Mangostin A method for isolating α-mangostin |
| 02/02/2006 | DE102004034623A1 Neue 6-Formyl-tetrahydropteridine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel New 6-formyl-tetrahydropteridines, processes for their preparation and their use as medicaments |
| 02/02/2006 | DE102004033834A1 New 1-sulfonyl-2-oxo-dihydroindole derivatives are selective antagonists of vasopressin receptors useful e.g. for treating hypertension, cardiac insufficiency, unstable angina or affective disorders |
| 02/02/2006 | DE102004033670A1 Neue Pyridodihydropyrazinone, Verfahren zu Ihrer Herstellung und Ihre Verwendung als Arzneimittel New Pyridodihydropyrazinone, process for their preparation and their use as medicaments |
| 02/02/2006 | DE102004031620A1 4-Trifluormethoxyphenoxybenzol-4`-sulfonsäuren, Verfahren zu ihrer Herstellung und Verwendung in Arzneimitteln 4-Trifluormethoxyphenoxybenzol-4`-sulfonic acids, process for their preparation and use in pharmaceuticals |
| 02/02/2006 | DE102004031569A1 Bulk production of storage-stable lyophilized mafosfamide lysine salt, for use as antitumor agent, by reacting another mafosfamide salt with packed ion exchange column charged with lysine and lyophilizing eluate |
| 02/02/2006 | CA2617188A1 Antimicrobial and/or antiviral composition and to methods for preparing and administering same |
| 02/02/2006 | CA2587019A1 Combination anticancer therapy and pharmaceutical compositions therefore |
| 02/02/2006 | CA2582252A1 Therapeutic use of anti-tf-antigen antibody |
| 02/02/2006 | CA2581693A1 New use |
| 02/02/2006 | CA2578332A1 Derivatives of pyrazoline, procedure for obtaining them and use thereof as therapeutic agents |
| 02/02/2006 | CA2575518A1 Medicinal composition as immunosuppressant |
| 02/02/2006 | CA2575411A1 Thiazole derivatives having vap-1 inhibitory activity |
| 02/02/2006 | CA2575376A1 Novel crystalline forms of 6alpha, 9alpha-difluoro-11beta hydroxy-16alpha-methyl-3-oxo-17alpha-propionyloxy-androsta-1,4-diene-17beta-carboxylic acid and processes for preparationthereof |
| 02/02/2006 | CA2575359A1 Piperazine derivatives useful for the treatment of gastrointestinal disorders |
| 02/02/2006 | CA2575341A1 Trpv1 agonists, formulations containing them and uses thereof |
| 02/02/2006 | CA2575283A1 Method for the preparation of crystal forms of torsemide in a pure state |
| 02/02/2006 | CA2575272A1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 02/02/2006 | CA2575254A1 Preparation of hydrochloride salts of tetrazole derivative |
| 02/02/2006 | CA2575243A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
| 02/02/2006 | CA2575223A1 Azaindole inhibitors of mtp and apob |
| 02/02/2006 | CA2575214A1 Substituted triazines as prion protein ligands and their use to detect or remove prions |
| 02/02/2006 | CA2575086A1 Compositions and methods for viscosupplementation |
| 02/02/2006 | CA2575006A1 Dosage forms with an enterically coated core tablet |
| 02/02/2006 | CA2574959A1 Antimicrobial peptides derived from cap18 |
| 02/02/2006 | CA2574947A1 Guanidine derivatives and therapeutic uses thereof |
| 02/02/2006 | CA2574920A1 Pharmaceutical combinations containing an inhibitor of platelet aggregation and a fibrate |
| 02/02/2006 | CA2574894A1 Physiologically active composition |
| 02/02/2006 | CA2574685A1 Quinazolin-4-yl- piperidine and cinnolin-4-yl- piperidine derivatives as pde10 inhibitors for the treatment of cns disorders |
| 02/02/2006 | CA2574668A1 Oxazolidinone compounds and compositions and methods related thereto |
| 02/02/2006 | CA2574664A1 Compound formulations of 2-amino-1,3-propanediol compounds |
| 02/02/2006 | CA2574660A1 Salt of oxalic acid with 5-[4-[2-(n-methyl-n-(2-pyridyl)-amino)ethoxy]benzyl]thiazolidin-2,4-dione and a method of its preparation and its use |
| 02/02/2006 | CA2574627A1 Compositions for treatment of inflammation and pain using a combination of a cox-2 selective inhibitor and a ltb4 receptor antagonist |
| 02/02/2006 | CA2574608A1 Novel glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 02/02/2006 | CA2574602A1 Taste masking formulation comprising the drug in a dissolution-retarded form and/or cyclodextrin in a dissolution-enhanced form |
| 02/02/2006 | CA2574594A1 Imidazopyrazine as tyrosine kinase inhibitors |
| 02/02/2006 | CA2574466A1 Treatment for ocular disease |
| 02/02/2006 | CA2574451A1 D-glucopyranosyl phenyl-substituted cyclene, medicaments containing these compounds, their use, and method for the production thereof |
| 02/02/2006 | CA2574420A1 Method for treating nervous system disorders and conditions |
| 02/02/2006 | CA2574418A1 Peptidase inhibitors |
| 02/02/2006 | CA2574361A1 1, 3 substituted cycloamino derivatives and their use as histamine-3 receptor antagonists |
| 02/02/2006 | CA2574315A1 Method for treating nervous system disorders and conditions |
| 02/02/2006 | CA2574313A1 Inhibitors of hsp90 |
| 02/02/2006 | CA2574310A1 Method for treating nervous system disorders and conditions |
| 02/02/2006 | CA2574308A1 Benzyltriazolone compounds as non-nucleoside reverse transcriptase inhibitors |
| 02/02/2006 | CA2574307A1 Rifamycin derivatives for treating microbial infections |
| 02/02/2006 | CA2574305A1 1, 1a, 5, 5a-tetrahydro-s-thia-cyclopropa'a! pentalenes: tricyclic thiophene derivatives as s1p1/edg1 receptor agonists |
| 02/02/2006 | CA2574301A1 (r/s) rifamycin derivatives, their preparation and pharmaceutical compositions |
| 02/02/2006 | CA2574169A1 New heterocyclic carboxylic acid amide derivatives |
| 02/02/2006 | CA2574167A1 Kynurenic acid amide derivatives as nr2b receptor antagonists |
| 02/02/2006 | CA2574158A1 New benzoyl urea derivatives |
| 02/02/2006 | CA2574155A1 Indole-2 -carboxamidine derivatives as nmda receptor antagonists |
| 02/02/2006 | CA2574148A1 4-benzylidene-piperidine derivatives |
| 02/02/2006 | CA2574139A1 Inhibitors of hsp90 |
| 02/02/2006 | CA2574021A1 Tyrosine derivatives as ppar-gamma-modulators |
| 02/02/2006 | CA2573949A1 Epothilone combinations |
| 02/02/2006 | CA2573920A1 Histamine-3 receptor antagonists |
| 02/02/2006 | CA2573777A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 02/02/2006 | CA2573774A1 Crystalline lactosucrose or molasses-containing crystal having the same contained therein, and use thereof |
| 02/02/2006 | CA2573543A1 N-phenylphosphoric acid triamides, method for the production thereof and their use as agents for regulating or inhibiting enzymatic urea hydrolysis |
| 02/02/2006 | CA2573538A1 Inhibitors of vegf receptor and hgf receptor signaling |
| 02/02/2006 | CA2573426A1 Pyrrole derivatives as pharmaceutical agents |
| 02/02/2006 | CA2573412A1 Formulation for stimulating hair growth |
| 02/02/2006 | CA2573122A1 Use of compounds active on the sigma receptor for the treatment of mechanical allodynia |
| 02/02/2006 | CA2572971A1 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
| 02/02/2006 | CA2572970A1 Substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/02/2006 | CA2572833A1 Substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylase |
| 02/02/2006 | CA2572287A1 Carboranylporphyrins and uses thereof |
| 02/02/2006 | CA2571926A1 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| 02/02/2006 | CA2571668A1 4-substituted quinoline derivatives, method and intermediates for preparing same and pharmaceutical compositions containing same |
| 02/02/2006 | CA2571587A1 Quaternary salt ccr2 antagonists |
| 02/02/2006 | CA2571424A1 Bisarylurea derivatives useful for inhibiting chk1 |
| 02/02/2006 | CA2571347A1 Piperazine derivatives for the treatment of female sexual disorders |
| 02/02/2006 | CA2571324A1 Heterocycle-substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/02/2006 | CA2571223A1 Quinazoline derivatives |
| 02/02/2006 | CA2571079A1 Nucleoside aryl phosphoramidates for the treatment of rna-dependent rna viral infection |
| 02/02/2006 | CA2571045A1 Pharmaceutical formulation based on antibiotic in microcapsule form |
| 02/02/2006 | CA2570994A1 Estrogen receptor modulators |
| 02/02/2006 | CA2570903A1 N-hydroxyamide derivatives and use thereof |
| 02/02/2006 | CA2570729A1 Novel angiogenesis inhibitors and pharmaceutical and cosmetic use thereof |
| 02/02/2006 | CA2570694A1 Amido compounds and their use as pharmaceuticals |
| 02/02/2006 | CA2570688A1 Compounds and methods for treating dyslipidemia |
| 02/02/2006 | CA2570637A1 N-substituted piperidines and their use as pharmaceuticals |
| 02/02/2006 | CA2570634A1 1 (indole-6-carbonyl-d-phenylglycinyl) -4- (1-methylpiperidin-4-yl) piperazine d-tartrate |
| 02/02/2006 | CA2570608A1 Multiparticle pharmaceutical form for low-solubility active substances and a process for preparing the pharmaceutical form |